Roche, Sangamo Ink Licensing Deal for Neuro Drugs
Roche Holding Non-GAAP EPS of CHF 10.23, Revenue of CHF 29.85B; Raises FY24 Outlook
Reported Thursday, Roche's Genentech Halts SKYSCRAPER-06 Trial After Tiragolumab Plus Tecentriq And Chemotherapy Show Reduced Efficacy Compared To Comparator Arm
Roche's Genentech Receives FDA Approval For Vabysmo Prefilled Syringe (PFS) To Treat Three Leading Causes Of Vision Loss
Roche's VENTANA DP 200 Digital System Approved For Diagnostic Use By FDA
Reported Saturday, Genentech's Phase III STARGLO Study Shows Columvi Increases Survival For Patients With Relapsed Or Refractory Diffuse Large B-cell Lymphoma
Roche's Genentech Granted Priority Review By FDA For Inavolisib, An Investigational Oral Therapy, In Combination With Palbociclib (Ibrance) And Fulvestrant
Reported Earlier, Roche And Hitachi High-Tech Extend 46-Year Partnership For Diagnostic Testing Advances
Hedge Funds Tilt Back Into Secular Growth in Feb, Keep Risk Profile High - Jefferies
Reported Earlier, Roche's Genentech Announced Data From Stage 1 Of The National Institutes Of Health (NIH)-Sponsored Pivotal Phase III Outmatch Study Evaluating The Efficacy And Safety Ofxolair
Roche Collaborates With PathAI To Expand Digital Pathology Capabilities For Companion Diagnostics
Roche Holding Non-GAAP EPS of CHF 18.57, Revenue of CHF 58.72B; Initiates FY24 Outlook
Roche's Genentech Announces New 72-Week Data From BALATON And COMINO, Evaluating Vabysmo In Macular Edema Due To Branch And Central Retinal Vein Occlusion
Roche's Genentech Vabysmo New Long-Term Data Shows Sustained Retinal Drying And Vision Improvements In Retinal Vein Occlusion (RVO)
Is Vanguard International Dividend Appreciation ETF (VIGI) a Strong ETF Right Now?
Roche Receives European Commission Approval of Tecentriq SC With Halozyme's ENHANZE Representing The EU's First Subcutaneous PD-(L)1 Cancer Immunotherapy For Multiple Cancer Types
Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M
Roche Navify Digital Solutions Earns Excellent Ratings From Healthcare Professionals In KLAS Research
Vanguard International Dividend Appreciation Etf To Go Ex-Dividend On December 18th, 2023 With 0.3743 USD Dividend Per Share
Vanguard International Dividend Appreciation ETF Declares Quarterly Distribution of $0.3743